Form 4 for LUCD Lucid Diagnostics Inc.

Accepted 2023-09-22 00:00:00 ET · period of report 2023-09-20 · accession 0001062993-23-018421 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-09-22	2023-09-20+	LUCD	Lapidus Stanley	Dir	S - Sale	$1.45	-3,917	131.5K	-3%	-$5,675

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common stock	2023-09-20	S	D	412	$1.44	131,639	D	—	—	(F2) Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023.
2	Common	Common stock	2023-09-20	S	D	3,405	$1.45	132,051	D	—	—	(F2) Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023.
3	Common	Common stock	2023-09-21	S	D	100	$1.44	131,539	D	—	—	(F2) Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023.